| Compounds, Mechanisms, Delivery Systems |
Indications |
| NFEPP i.v. or s.c. | Inflammatory, postsurgical and breakthrough cancer pain |
|
New NFEPP formulations: topical, patch, tablet, sustained release |
Chronic musculoskeletal pain, neuropathy, chronic cancer pain, wounds, migraine |
| NFEPP derivatives, anti-inflammatory effects | Arthritis, IBD, pancreatitis, itch, cancer, migraine |
| pH-dependent ligands for non-opioid receptors | Chronic pain, inflammation, cancer, migraine |
Projected NFEPP Market Share
(adapted from Nature Reviews/Drug Discovery 2010;9:589)
